Five years ago, the spread of the Covid-19 virus gave politicians the excuse to go full totalitarian. Their fear-based ...

VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

“Pharma continues turning to AI to better understand diseases and speed up drug discovery and development,” said Noam Solomon ...

(Reuters) - Kohl's on Friday changed the title of its chief DEI officer and broadened its supplier diversity program in ...

Beyond the ACS, Do No Harm has also launched similar lawsuits that target diversity, equity and inclusion (DEI)-related ...

Korean Air unveiled a new corporate logo and aircraft livery as part of a wide-ranging brand refresh following its ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of ...

An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.